Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
Clinical Research Facility
mi
from
Portland metropolitan area, OR
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
Clinical Research Facility
mi
from
Portland metropolitan area, OR
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
Clinical Research Facility
mi
from
Delaware County, PA
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
Clinical Research Facility
mi
from
Delaware County, PA
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
Clinical Research Facility
mi
from
Philadelphia County, PA
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
Clinical Research Facility
mi
from
Philadelphia County, PA
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
Clinical Research Facility
mi
from
Charleston County, SC
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
Clinical Research Facility
mi
from
Charleston County, SC
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
Clinical Research Facility
mi
from
Salt Lake County, UT
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
Clinical Research Facility
mi
from
Salt Lake County, UT
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
Clinical Research Facility
mi
from
Benton County, WA
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
Clinical Research Facility
mi
from
Benton County, WA
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
mi
from
Marion County, AL
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
mi
from
Marion County, AL
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
mi
from
Winston County, AL
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
mi
from
Winston County, AL
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
mi
from
Maricopa County, AZ
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
mi
from
Maricopa County, AZ
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
mi
from
Orlando metropolitan area, FL
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
mi
from
Orlando metropolitan area, FL
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
mi
from
Chicago metropolitan area, IL
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
mi
from
Chicago metropolitan area, IL
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
mi
from
Rankin County, MS
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
mi
from
Rankin County, MS
Click here to add this to my saved trials
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated:  9/28/2015
mi
from
St. Louis metropolitan area, MO
Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence
A Multi-center, Open-Label, 24-Week, Follow-Up Study to Assess Safety, Efficacy, and Treatment Adherence For Maintenance Treatment of Opioid Dependence With OX219
Status: Enrolling
Updated: 9/28/2015
mi
from
St. Louis metropolitan area, MO
Click here to add this to my saved trials
Does Preop Midazolam Maintain Blood Glucose Norms in the Non Diabetic Perioperative Period
Does the Administration of Preop Midazolam Assist in Maintaining Blood Glucose Norms in Non-diabetic Patient During the Perioperative Period
Status: Enrolling
Updated:  9/29/2015
University Hospital
mi
from
Newark, NJ
Does Preop Midazolam Maintain Blood Glucose Norms in the Non Diabetic Perioperative Period
Does the Administration of Preop Midazolam Assist in Maintaining Blood Glucose Norms in Non-diabetic Patient During the Perioperative Period
Status: Enrolling
Updated: 9/29/2015
University Hospital
mi
from
Newark, NJ
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
University of Colorado, School of Medicine
mi
from
Aurora, CO
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
University of Colorado, School of Medicine
mi
from
Aurora, CO
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Denver VA Medical Center-ECHCS
mi
from
Denver, CO
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Denver VA Medical Center-ECHCS
mi
from
Denver, CO
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
University of Pennslvania Abramson Cancer Center
mi
from
Philadelphia, PA
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
University of Pennslvania Abramson Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Mary Crowley Cancer Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Virginia Cancer Specialists, PC
mi
from
Fairfax, VA
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
University of California-Davis Comprehensive Cancer Ctr
mi
from
Sacramento, CA
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Stanford Cancer Institute
mi
from
Stanford, CA
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Stanford Cancer Institute
mi
from
Stanford, CA
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Veterans Administration New Jersey Health Care System
mi
from
East Orange, NJ
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Veterans Administration New Jersey Health Care System
mi
from
East Orange, NJ
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Montefiore Medical Center
mi
from
Bronx, NY
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Mount Sinai Hospital
mi
from
New York, NY
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
The Ohio State University James Cancer Hospital
mi
from
Columbus, OH
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
The Ohio State University James Cancer Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/30/2015
Blue Ridge Cancer Care
mi
from
Salem, VA
Oral Rigosertib for Squamous Cell Carcinoma
A Phase II Study of Oral Rigosertib in Patients With Relapsed or Metastatic, Platinum-resistant, Human Papillomavirus Positive or Negative Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/30/2015
Blue Ridge Cancer Care
mi
from
Salem, VA
Click here to add this to my saved trials
Vaginal Creams to Reduce Vaginal Erosion in Pessary Users
Vaginal Creams for Reduction of Vaginal Discharge and Erosion in Patients Using Ring With Support or Gellhorn Pessaries to Reduce Pelvic Organ Prolapse
Status: Enrolling
Updated:  9/30/2015
Division of Urogynecology North Shore-LIJ School of Medicine
mi
from
Great Neck, NY
Vaginal Creams to Reduce Vaginal Erosion in Pessary Users
Vaginal Creams for Reduction of Vaginal Discharge and Erosion in Patients Using Ring With Support or Gellhorn Pessaries to Reduce Pelvic Organ Prolapse
Status: Enrolling
Updated: 9/30/2015
Division of Urogynecology North Shore-LIJ School of Medicine
mi
from
Great Neck, NY
Click here to add this to my saved trials
Vitamin D Administration in the Nursing Home
Intermittent Vitamin D Administration in the Nursing Home: Impact on Vitamin D Status, Falls, Bone Turnover and Bone Density
Status: Enrolling
Updated:  9/30/2015
University of Wisconsin
mi
from
Madison, WI
Vitamin D Administration in the Nursing Home
Intermittent Vitamin D Administration in the Nursing Home: Impact on Vitamin D Status, Falls, Bone Turnover and Bone Density
Status: Enrolling
Updated: 9/30/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Molecular Epidemiology of Barrett's Esophagus
Status: Enrolling
Updated:  9/30/2015
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Molecular Epidemiology of Barrett's Esophagus
Status: Enrolling
Updated: 9/30/2015
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Molecular Epidemiology of Barrett's Esophagus
Status: Enrolling
Updated:  9/30/2015
Harvard School of Public Health
mi
from
Boston, MA
Risk Factors for Barrett's Esophagus in Patients With BE, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Molecular Epidemiology of Barrett's Esophagus
Status: Enrolling
Updated: 9/30/2015
Harvard School of Public Health
mi
from
Boston, MA
Click here to add this to my saved trials
Correction of Vitamin D Inadequacy in Nursing Home Residents
Effect of Vitamin D Supplementation on Skeletal and Overall Health of Nursing Home Residents
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin
mi
from
Madison, WI
Correction of Vitamin D Inadequacy in Nursing Home Residents
Effect of Vitamin D Supplementation on Skeletal and Overall Health of Nursing Home Residents
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)
Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin
mi
from
Madison, WI
Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)
Pilot Study of the Role of PET-CT for Diagnosis and Assessment of Therapeutic Efficacy in Inflammatory Bowel Disease
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Evaluation of Potential Vitamin D Effects on Muscle: a Pilot Study
Evaluation of Potential Vitamin D Effects on Muscle: a Pilot Study
Status: Enrolling
Updated:  10/1/2015
UW Osteoporosis Clinical Research Program
mi
from
Madison, WI
Evaluation of Potential Vitamin D Effects on Muscle: a Pilot Study
Evaluation of Potential Vitamin D Effects on Muscle: a Pilot Study
Status: Enrolling
Updated: 10/1/2015
UW Osteoporosis Clinical Research Program
mi
from
Madison, WI
Click here to add this to my saved trials
Clinical Approaches to Correcting Vitamin D Inadequacy and Maintaining Adequacy
Clinical Approaches to Correcting Vitamin D Inadequacy and Maintaining Adequacy
Status: Enrolling
Updated:  10/1/2015
UW Osteoporosis Clinical Research Program
mi
from
Madison, WI
Clinical Approaches to Correcting Vitamin D Inadequacy and Maintaining Adequacy
Clinical Approaches to Correcting Vitamin D Inadequacy and Maintaining Adequacy
Status: Enrolling
Updated: 10/1/2015
UW Osteoporosis Clinical Research Program
mi
from
Madison, WI
Click here to add this to my saved trials
Improving Women's Health by Using an Electronic Pelvic Floor Questionnaire
Improving the Assessment of Women's Health Through the Use of a Computerized Pelvic Floor Questionnaire
Status: Enrolling
Updated:  10/1/2015
UW Health Women's Health Internal Medicine West
mi
from
Madison, WI
Improving Women's Health by Using an Electronic Pelvic Floor Questionnaire
Improving the Assessment of Women's Health Through the Use of a Computerized Pelvic Floor Questionnaire
Status: Enrolling
Updated: 10/1/2015
UW Health Women's Health Internal Medicine West
mi
from
Madison, WI
Click here to add this to my saved trials
The Effect of Vitamin D Statues on Endothelial Function
The Effect of Vitamin D Statues on Endothelial Function
Status: Enrolling
Updated:  10/1/2015
University of Wisconsin Osteoporosis Clinical and Research Program
mi
from
Madison, WI
The Effect of Vitamin D Statues on Endothelial Function
The Effect of Vitamin D Statues on Endothelial Function
Status: Enrolling
Updated: 10/1/2015
University of Wisconsin Osteoporosis Clinical and Research Program
mi
from
Madison, WI
Click here to add this to my saved trials
Efficacy of Vitamin D Therapy on Glucose Homeostasis in Obese Adolescents
Efficacy of Vitamin D Therapy on Glucose Homeostasis in Obese Adolescents
Status: Enrolling
Updated:  10/5/2015
bellevue hospital CTSI
mi
from
New York, NY
Efficacy of Vitamin D Therapy on Glucose Homeostasis in Obese Adolescents
Efficacy of Vitamin D Therapy on Glucose Homeostasis in Obese Adolescents
Status: Enrolling
Updated: 10/5/2015
bellevue hospital CTSI
mi
from
New York, NY
Click here to add this to my saved trials
Preoperative Nutritional Support in Esophagectomy or Pancreaticoduodenectomy
Preoperative Nutritional Support Reduces Postoperative Stay and Incidence of Complications in Patients Undergoing an Esophagectomy or Pancreaticoduodenectomy
Status: Enrolling
Updated:  10/6/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Preoperative Nutritional Support in Esophagectomy or Pancreaticoduodenectomy
Preoperative Nutritional Support Reduces Postoperative Stay and Incidence of Complications in Patients Undergoing an Esophagectomy or Pancreaticoduodenectomy
Status: Enrolling
Updated: 10/6/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Can Simple and Inexpensive Techniques Enhance Patient Comfort
Can Simple and Inexpensive Techniques Enhance Patient Comfort in Sedation Risk-free Screening and Surveillance Colonoscopy?
Status: Enrolling
Updated:  10/6/2015
VA Greater Los Angeles Healthcare System, Sepulveda, CA
mi
from
Sepulveda, CA
Can Simple and Inexpensive Techniques Enhance Patient Comfort
Can Simple and Inexpensive Techniques Enhance Patient Comfort in Sedation Risk-free Screening and Surveillance Colonoscopy?
Status: Enrolling
Updated: 10/6/2015
VA Greater Los Angeles Healthcare System, Sepulveda, CA
mi
from
Sepulveda, CA
Click here to add this to my saved trials
Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.
A STUDY OF CRYOSPRAY ABLATIONTM USING SURGICAL RESECTION SPECIMENS TO DETERMINE TREATMENT EFFECT, DEPTH OF INJURY, AND SIDE EFFECTS IN THE ESOPHAGUS (CSA Depth 3)
Status: Enrolling
Updated:  10/6/2015
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Study of CryoSpray Ablation(TM)to Determine Treatment Effect, Depth of Injury, and Side Effects in the Esophagus.
A STUDY OF CRYOSPRAY ABLATIONTM USING SURGICAL RESECTION SPECIMENS TO DETERMINE TREATMENT EFFECT, DEPTH OF INJURY, AND SIDE EFFECTS IN THE ESOPHAGUS (CSA Depth 3)
Status: Enrolling
Updated: 10/6/2015
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Treatment of Vitamin D Insufficiency
Treatment of Vitamin D Insufficiency
Status: Enrolling
Updated:  10/6/2015
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Treatment of Vitamin D Insufficiency
Treatment of Vitamin D Insufficiency
Status: Enrolling
Updated: 10/6/2015
University of Wisconsin School of Medicine and Public Health
mi
from
Madison, WI
Click here to add this to my saved trials
An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant Ascites
An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant Ascites
Status: Enrolling
Updated:  10/6/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant Ascites
An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Pleurx Catheters in Patients With Malignant Ascites
Status: Enrolling
Updated: 10/6/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated:  10/6/2015
Ann & Robert H. Lurie Children's Hospital of Chicago (NWU)
mi
from
Chicago, IL
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated: 10/6/2015
Ann & Robert H. Lurie Children's Hospital of Chicago (NWU)
mi
from
Chicago, IL
Click here to add this to my saved trials
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated:  10/6/2015
Indiana University
mi
from
Indianapolis, IN
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated: 10/6/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated:  10/6/2015
St. Louis University
mi
from
St. Louis, MO
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated: 10/6/2015
St. Louis University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated:  10/6/2015
Columbia University
mi
from
New York, NY
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated: 10/6/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated:  10/6/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated: 10/6/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated:  10/6/2015
Texas Children's Hospital
mi
from
Houston, TX
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated: 10/6/2015
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated:  10/6/2015
University of Washington, Seattle Children's Hospital
mi
from
Seattle, WA
Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children
Cysteamine Bitartrate Delayed-Release for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Children (CyNCh)
Status: Enrolling
Updated: 10/6/2015
University of Washington, Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials